These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7944347)

  • 1. An approach to sequence-specific antibody proteases. The use of haptens mimicking both a transition state and a distorted ground state.
    Smith RM; Yuan P; Weiner DP; Dutton CR; Hansen DE
    Appl Biochem Biotechnol; 1994; 47(2-3):329-42; discussion 342-3. PubMed ID: 7944347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of five enantiomerically pure haptens designed for in vitro evolution of antibodies with peptidase activity.
    Wagner J; Lerner RA; Barbas CF
    Bioorg Med Chem; 1996 Jun; 4(6):901-16. PubMed ID: 8818241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cleavage specificity of a proteolytic antibody light chain and effects of the heavy chain variable domain.
    Sun M; Gao QS; Kirnarskiy L; Rees A; Paul S
    J Mol Biol; 1997 Aug; 271(3):374-85. PubMed ID: 9268666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural catalytic antibodies.
    Paul S
    Mol Biotechnol; 1996 Jun; 5(3):197-207. PubMed ID: 8837026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hapten design for the generation of catalytic antibodies.
    Thomas NR
    Appl Biochem Biotechnol; 1994; 47(2-3):345-72. PubMed ID: 7944348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody proteases: induction of catalytic response.
    Gabibov AG; Friboulet A; Thomas D; Demin AV; Ponomarenko NA; Vorobiev II; Pillet D; Paon M; Alexandrova ES; Telegin GB; Reshetnyak AV; Grigorieva OV; Gnuchev NV; Malishkin KA; Genkin DD
    Biochemistry (Mosc); 2002 Oct; 67(10):1168-79. PubMed ID: 12460115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of catalytic antibody repertoire in autoimmune mice.
    Nishi Y
    J Immunol Methods; 2002 Nov; 269(1-2):213-33. PubMed ID: 12379363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of a catalytic antibody with a serine protease active site.
    Zhou GW; Guo J; Huang W; Fletterick RJ; Scanlan TS
    Science; 1994 Aug; 265(5175):1059-64. PubMed ID: 8066444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transition state docking: a probe for noncovalent catalysis in biological systems. Application to antibody-catalyzed ester hydrolysis.
    Tantillo DJ; Houk KN
    J Comput Chem; 2002 Jan; 23(1):84-95. PubMed ID: 11913392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple reactive immunization towards the hydrolysis of organophosphorus nerve agents: hapten design and synthesis.
    Huang H; Han WG; Noodleman L; Grynszpan F
    Bioorg Med Chem; 2001 Dec; 9(12):3185-95. PubMed ID: 11711294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspects of antibody-catalyzed primary amide hydrolysis.
    Titmas RC; Angeles TS; Sugasawara R; Aman N; Darsley MJ; Blackburn G; Martin MT
    Appl Biochem Biotechnol; 1994; 47(2-3):277-90; discussion 291-2. PubMed ID: 7944343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of flexible and constrained haptens in eliciting antibody catalysts for paraoxon hydrolysis.
    Spivak DA; Hoffman TZ; Moore AH; Taylor MJ; Janda KD
    Bioorg Med Chem; 1999 Jun; 7(6):1145-50. PubMed ID: 10428386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Directed evolution governed by controlling the molecular recognition between an abzyme and its haptenic transition-state analog.
    Takahashi-Ando N; Kakinuma H; Fujii I; Nishi Y
    J Immunol Methods; 2004 Nov; 294(1-2):1-14. PubMed ID: 15604011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The elicitation of carboxylesterase activity in antibodies by reactive immunization with labile organophosphorus antigens: a role for flexibility.
    Schowen RL
    J Immunol Methods; 2002 Nov; 269(1-2):59-65. PubMed ID: 12379352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Origins and predictions of stereoselective antibody catalysis: theoretical analysis of Diels-Alder catalysis by 39A11 and its germ-line antibody.
    Zhang X; Deng Q; Yoo SH; Houk KN
    J Org Chem; 2002 Dec; 67(25):9043-53. PubMed ID: 12467427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A glycosidase antibody elicited against a chair-like transition state analog by in vitro immunization.
    Yu J; Choi SY; Moon KD; Chung HH; Youn HJ; Jeong S; Park H; Schultz PG
    Proc Natl Acad Sci U S A; 1998 Mar; 95(6):2880-4. PubMed ID: 9501184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody catalysis of peptide bond formation.
    Jacobsen JR; Schultz PG
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5888-92. PubMed ID: 8016084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmenting the efficacy of anti-cocaine catalytic antibodies through chimeric hapten design and combinatorial vaccination.
    Wenthur CJ; Cai X; Ellis BA; Janda KD
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3666-3668. PubMed ID: 28709828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catalytic activity of antibodies against factor VIII in patients with hemophilia A.
    Lacroix-Desmazes S; Moreau A; Sooryanarayana ; Bonnemain C; Stieltjes N; Pashov A; Sultan Y; Hoebeke J; Kazatchkine MD; Kaveri SV
    Nat Med; 1999 Sep; 5(9):1044-7. PubMed ID: 10470082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide synthesis catalyzed by an antibody containing a binding site for variable amino acids.
    Hirschmann R; Smith AB; Taylor CM; Benkovic PA; Taylor SD; Yager KM; Sprengeler PA; Benkovic SJ
    Science; 1994 Jul; 265(5169):234-7. PubMed ID: 8023141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.